Journals / Endokrinolojide Diyalog Dergisi / 2009 / Cilt: 6 - Sayı: 2

Evaluation of hemostatic parameters in type 1 and type 2 diabetic patients and their relationship with diabetic vascular complications

Tip 1 ve tip 2 diyabetik hastalarda hemostatik parametrelerin değerlendirilmesi ve diyabetik vasküler komplikasyonlar ile ilişkisi

Pages
78–86
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Other factors were not found to be linked with micro- and macrovascular complications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Coagulation abnormalities occur in the course of diabetes mellitus, resulting in a state of thrombophilia.
📊
Key Findings & Data:The aim of this study was to evaluate factors of hemostatic system in type 1 and type 2 diabetes mellitus patients taking into account metabolic control, blood lipids and diabetic complications.
💡
Conclusion & Impact:Other factors were not found to be linked with micro- and macrovascular complications.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Coagulation abnormalities occur in the course of diabetes mellitus, resulting in a state of thrombophilia. A hypercoagulable state associated with metabolic disturbance may contribute to micro- and macrovascular disease. The aim of this study was to evaluate factors of hemostatic system in type 1 and type 2 diabetes mellitus patients taking into account metabolic control, blood lipids and diabetic complications. The study population consisted of 48 patients with type 1 diabetes (age: 27.93±1.06 years), 22 patients with type 2 diabetes (age: 54.41±1.72 years) and 47 healthy subjects (age: 27.89±1.24 years). The plasma levels of fibrinogen, coagulation factors II, V, VII, VIII, IX, X, protein C, protein S, and antithrombin III were determined. HbA1c levels were high both in type 1 and 2 diabetic patients (9.31±0.30 and 8.28±1.87% respectively). There was no significant difference in antithrombin III, protein C, protein S, and factor VIII levels between the groups. The mean factor V, VII, IX and X levels in patients with type 1 diabetes mellitus were elevated markedly compared with healthy subjects. Fibrinogen level was significantly increased in both type 1 and 2 diabetic patients with or without diabetic complications. Factor II level was found to be low in patients with type 2 diabetes compared with healthy subjects. Factor V and VII levels were correlated with triglyceride levels and factor X, antithrombin III with total cholestrol levels. Protein C levels were significantly low in diabetic patients with autonomic neuropathy. Factor X levels were high in patients with peripheric neuropathy. There was no significant correlation of these hemostatic factors with metabolic control. The analysis shows no significant difference between the groups. Other factors were not found to be linked with micro- and macrovascular complications.

Özet

Diabetes mellitusta trombofiliye neden olan pıhtılaşma anormallikleri olduğu bilinmektedir. Kötü metabolik kontrol ile ilişkili görünen trombofilinin mikro- ve makrovasküler hastalığa yolaçabileceği düşünülmektedir. Bu çalışmanın amacı, diabetes mellituslu hastalarda metabolik kontrol, kan lipidleri ve diyabetik komplikasyonları gözönüne alarak hemostatik sistem faktörlerini incelemektir. Çalışma grubu, 48 tip 1 diyabetik (yaş: 27.93±1.06 yıl), 22 tip 2 diyabetik hastadan (yaş: 54.41±1.72 yıl) ve 47 sağlıklı kişiden (yaş: 27.89±1.24 yıl) oluşturuldu. Fibrinojen, pıhtılaşma faktörü II, V, VII, VIII, IX, X, protein C, protein S ve antitrombin III düzeyleri çalışıldı. HbA1c düzeyleri hem tip 1 ve hem tip 2 diyabetik hastalarda yüksekti (sırasıyla %9.31±0.30 ve %8.28±1.87). Antitrombin III, protein C, protein S ve faktör VIII düzeyleri gruplar arasında farklı saptanmadı. Tip 1 diabetes mellituslu hastalarda, faktör V, VII, IX ve X düzeyleri sağlıklı bireylerle karşılaştırıldığında belirgin yüksek tespit edildi. Fibrinojen düzeyi diyabetik komplikasyonu olan ve olmayan tip 1 ve tip 2 diyabetik hastalarda yüksek bulundu. Faktör II düzeyi, tip 2 diyabetik hastalarda kontrollere göre düşük saptandı. Faktör V ve VII'nin trigliserid düzeyleri ile, faktör X ve antitrombin III'ün total kolesterol düzeyleri ile ilişkili olduğu bulundu. Otonomik nöropatisi olan hastalarda protein C düzeyleri düşük, periferik nöropatisi olan hastalarda faktör X düzeyleri belirgin yüksek tespit edildi. Bu hemostatik faktörlerin metabolik kontrol ile bir ilişkisi gözlenmedi. Diğer faktörler ile mikro- ve makrovasküler komplikasyonlar arasında ilişki saptanmadı.

🔖

Cite This Article

NAR, A., ERBAŞ, T. (2022). Evaluation of hemostatic parameters in type 1 and type 2 diabetic patients and their relationship with diabetic vascular complications. Endokrinolojide Diyalog Dergisi, Cilt: 6 - Sayı: 2, 78–86. https://ajindex.com/articles/500821

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ceriello A. Coagulation activation in diabetes mellitus: The role of hyperglycemia and therapeutic prospects. Diabetologia 1993;36:1119-25
  2. Colwell JA. Vascular thrombosis in type 2 diabetes mellitus. Diabetes 1993;42:8-11
  3. Dunn EJ, Grant PJ. Type 2 diabetes: an atherothrombotic syndrome. Curr Mol Med 2005;5:323-32
  4. Calles-Escandon J, Garcia-Rubi E, Mirza S, Mortensen A. Type 2 diabetes: One disease, multiple cardiovascular risk factors. Coron Artery Dis 1999;10:23-30
  5. Knöbl P, Schernthaner G, Schnack C, et al. Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1993;36:1045-50
  6. El Khawand C, Jamart J, Donckier J, et al. Hemostasis variables in type 1 diabetic patients without demonstrable vascular complications. Diabetes Care 1993;16:1137-45
  7. Kwaan HC. Changes in blood coagulation, platelet function and plasminogen-plasmin system in diabetes. Diabetes 1992;41: 32-5
  8. Williams E, Timperley WR, Ward JD, Duckworth T. Electron microscopical studies of vessels in diabetic peripheral ne 1. Ceriello A. Coagulation activation in diabetes mellitus: The role of hyperglycemia and therapeutic prospects. Diabetologia 1993;36:1119-25
  9. Krishnaswarmi A, Carr ME, Jesse RL, et al. Patients with coronary artery disease who present with chest pain have significantly elevated platelet contractile force. Thromb Haemostasis 1999;82:162
  10. Sahli D, Eriksson JW, Boman K, Svensson MK. Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes. Thromb Res 2008;20. [Epub ahead of print] 11. Carr ME. Diabetes mellitus: A hypercoagulable state. J Diabetes Complications 2001;15:44-54
  11. Kario K, Matsuo T, Kobayashi M, Matsuo M, Sakata T, Miyata T. Activation of tissue factor induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria. Arterioscler Thromb Vasc Biol 1995;15:1114-20
  12. Kvasnicka J, Skrha J, Perusicova J, et al. Haemostasis, cytoadhesive molecules (sE-selectin and sICAM-1) and inflammatory markers in non-insulin-dependent diabetes mellitus. Sb Lek 1998;99:97-101
  13. Le DS, Miles R, Savage PJ, et al. The association of plasma fibrinogen concentration with diabetic microvascular complications in young adults with early-onset of type 2 diabetes. Diabetes Res Clin Pract 2008;82:317-23
  14. Erem C, Hacihasanoğlu A, Celik S, e